Injectable Drug Packaging Market
Injectable Drug Packaging Market Trends Analysis, By Product Type (Ampules, Vials, Cartridges), By Type (Devices, Formulations), By End-Use (Hospitals & Clinics, Home Care Settings), By Price (Below US$ 1, US$ 1 – US$ 3), By Sales Channel & By Region Forecast - Global Review 2021 to 2031
Analysis of Injectable Drug Packaging Market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Injectable Drug Packaging Market Analysis
Injectable Drug Packaging Market is anticipated to expand steadily at CAGR of 11.2% to 11.8% during the forecast period of 2021 to 2031, projects Fact.MR in its latest research analysis of the global injectable drug packaging market.
The worldwide injectable packaging and additives marketplace has accelerated through the years and is anticipated to develop within-side the subsequent 4 years i.e. 2021 to 2025, especially because of growing drug consumption. The worldwide injectable packaging and additives marketplace is supported via way of means of numerous boom drivers inclusive of merging middle class in growing economies, a growing percentage of injectable in drug pipeline, growth in most cancers prevalence etc. Yet the stringent policies and rules related to drug packaging are obstructing the boom of the marketplace
What is Driving Demand for Injectable Drug Packaging Market?
Pharmaceutical packaging necessities are inspired with the aid of using the growing want for affected person self-management and the growing range of organic therapies, including cell and gene therapies, in addition to the cutting-edge trends in COVID-19 vaccines.
Therefore, corporations are looking for answers which can be greater superior and ready-to-use, in order that the drug product quality, safety, and efficacy are protected
New Product Development and E-commerce Channel Complementing the Market Sales
For bio-pharma companies and their injectable products, this new paradigm means that the right strategic production partners are now more valuable than ever. Today’s clinical and commercial teams need far more than a service provider who can handle drug product manufacturing. They need production experts who can provide multifaceted technical expertise, solution customization, and market foresight—not just prior to and at launch, but across the product lifecycle. These vital partners will not simply encourage bio-pharma companies to start with the end in mind. They’ll be there to help those companies navigate the continuing, dynamic evolution of those ends, as patient needs and market drivers continue to reshape the highest-value goals for new injectable products.
Alongside, chemical stability studies and E&L (extractables and leachables) profiles are becoming ever more important with new drugs entering the market. By working together closely with drug manufacturers, pharma packaging companies can leverage their knowledge to offer the best fit packaging for each unique formulation.
US and Canada Injectable Drug Packaging Market Outlook
North America is predicted to keep the biggest marketplace size in auto injector market at some point of the forecast period, accompanied through the European region. Factors include the growing prevalence of chronic diseases, increase of biological marketplace, and growing call for self-injection devices.
Also, Asia is the third-biggest marketplace for Needle-free injector marketplace. This marketplace is poised to witness the best growth because of the growing incidence of continual diseases, upward thrust in disposable income, developing attention on safety and comfort, and the growing range of partnerships on this marketplace space. Since the supply of products will be from US, it will become a driving factor to increase the demand in the market.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Europe Demand Outlook for Injectable Drug Packaging Market
Europe has been the second just behind North America with more than a third of the global market but with the emergence of China and other Asia-Pacific nations remains a threat, the increasing need for faster production and enhances shelf appeal are driving the market ahead. Some concerns to this market are the stringent regulations to pharmaceutical packaging by the governments across Europe, environmental concerns regarding the use of plastics, and the rising costs of raw materials used.
Furthermore, European Union (EU) regulations mandating pharmaceutical serialization in effect since February 2019, added with the US Drug Supply Chain Security Act compliance extended to 2023 is driving the serialization and track-and-trace efforts thereby are promoting pharmaceutical traceability and authenticity in the region. Similarly, other EU regulation now requires dimensional codes on the medical packaging to help identify the product and verify their authenticity leveraging the smartphone technology drives the digitalization of the packaging industry.
Who are the Key Manufacturers and Suppliers of Injectable Drug Packaging Market?
Some of the leading manufacturers and suppliers of Injectable Drugmarket include
- Dickinson and Company (U.S.)
- Pfizer Inc. (U.S.)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- Eli Lilly and Company (U.S.)
- Baxter International, Inc. (U.S.)
- Schott AG (Germany)
- Gerresheimer (Germany)
- Ypsomed (Switzerland)
- B. Braun Melsungen (Germany).
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Injectable Drug Packaging Market Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
By Product Type
- Hospitals & Clinics
- Home Care Settings
- Other Facilities of Use
- Below US$ 1
- US$ 1 – US$ 3
- US$ 30– US$ 10
- US$ 10 – US$ 30
- US$ 30 – US$ 60
- Above US$ 60
By Sales Channel
- Retail Pharmacy Stores
- Direct Sales
- Other Sales Channel
- North America
- US & Canada
- Latin America
- Brazil, Mexico, Others
- Western Europe
- Eastern Europe
- Asia Pacific
- Australia and New Zealand (ANZ)
- Greater China
- Rest of Asia Pacific
- Middle East and Africa
- GCC Countries
- Other Middle East
- North Africa
- South Africa
- Other Africa
- North America
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.
- FAQs -
According to the latest research report by Fact.MR, Injectable Drug Packaging market is anticipated to grow steadily at a CAGR of 11.2% to 11.8% during the forecast period of 2022 to 2032.
Pharmaceutical packaging requirements are being driven by the growing demand for patient self-management and the expanding range of organic therapies, which are driving the Injectable Drug Packaging market.
Because of the growing prevalence of chronic diseases, the expansion of the biological marketplace, and the growing demand for self-injection devices the Injectable Drug Packaging market will generate its major share in North America.
The injectable drug packaging market is likely to account for US$ 124.04 Billion in 2022.
The injectable drug packaging market has high growth potential due to the growing want for affected person self-management in middle-class economies.
The manufacturers in the injectable drug packaging industry are likely to find the most opportunities in the North American region.